+49 2066 50687-70

Pathogen detection by metagenomic next-generation sequencing during neutropenic fever in patients with haematological malignancies

Jan 1, 2021 | abstracts, publications

Febrile neutropenia (FN) following chemotherapy is a major cause of morbidity requiring urgent use of broad-spectrum antibiotics. Blood culture (BC) is a standard diagnostic method for FN but sensitivity of pathogen detection is low. Timely identification of causative pathogens using metagenomic next-generation sequencing (mNGS) of circulating cell-free DNA (cfDNA) from plasma could reduce morbidity and costs by enabling early-targeted antimicrobial therapy. The aim of this study is to establish mNGS (DISQVER) for the detection of pathogens within 24h in immunocompromised haematological patients with FN

Information for physicians

More precise diagnostics – more knowledge: Find out more about the clinical use of DISQVER!

How DISQVER works

Information for medical disciplines

Publications

News

Read more about Noscendo and DISQVER or visit us at trade fairs and conferences!

All News

Publications

Events

Press

Company

DISQVER together – get to know Noscendo!

Noscendo

Team

Advisory Board

Career